Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

However, the strong addiction and ... companies to develop non-narcotic pain relievers at that time was that they focused only on the development of drugs acting on a single receptor.

The long quest for powerful non-opioid drugs that treat pain without risk of addiction is nearing a milestone, in the form of a pill that could soon win approval from the Food and Drug Administration.

To tackle the opioid crisis, the Trump administration should push for the Alternatives to PAIN Act in Congress, which would ...

A Rutgers study shows acetaminophen and ibuprofen outperform opioids for pain relief after wisdom tooth removal, leading to better outcomes and supporting ADA guidance to avoid opioids as first-line ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids ... surgical and non-surgical pain settings. Treatment with the ...

The US regulator is carrying out a standard 10-month review of tanezumab as a treatment for chronic pain due to moderate ... that also has potential as a non-opioid painkiller.

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4.

This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ... A New Discovery About Pain Signaling May Contribute to Better Treatment of Chronic Pain Nov. 18 ...

Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before ...